Docosahexaenoic acid disruptsin vitroamyloid β1-40fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats-Reference-Cited by-同舟云学术

Docosahexaenoic acid disruptsin vitroamyloid β1-40fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats

Published:2008-12 Issue:6 Volume:107 Page:1634-1646
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Hashimoto Michio,Shahdat Hossain Md,Yamashita Shinji,Katakura Masanori,Tanabe Yoko,Fujiwara Hironori,Gamoh Shuji,Miyazawa Teruo,Arai Hiroyuki,Shimada Toshio,Shido Osamu

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2008.05731.x/fullpdf

Reference66 articles.

1. Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine;Beach;Neurosci. Lett.,2001

2. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins;Casserly;Lancet,2004

3. Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system;Dhopeshwarkar;Adv. Lipid Res.,1973

4. The pathogenesis of senile plaques;Dickson;J. Neuropathol. Exp. Neurol.,1997

5. Simvastatin strongly reduces levels of Alzheimer’s disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo;Fassbender;Proc. Natl Acad. Sci. USA,2001

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE;Progress in Lipid Research;2024-01

2. Brazilian green propolis prevent Alzheimer’s disease-like cognitive impairment induced by amyloid beta in mice;BMC Complementary Medicine and Therapies;2023-11-17

3. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy;Brain, Behavior, and Immunity;2023-07

4. Dietary supplementation in migraine: A focus on omega-3 fatty acids;Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders;2023

5. Esterification of Docosahexaenoic Acid Enhances Its Transport to the Brain and Its Potential Therapeutic Use in Brain Diseases;Nutrients;2022-10-28